OXALIPLATIN-BASED ADJUVANT CHEMOTHERAPY IN OLDER PATIENTS WITH STAGE III COLON CANCER: AN ACCENT/IDEA POOLED ANALYSIS OF 12 TRIALS. (03 Settembre 2024)
IMPROVED CLINICAL STAGING SYSTEM FOR LOCALIZED PANCREATIC CANCER USING THE ABC FACTORS: A TAPS CONSORTIUM STUDY. (18 Giugno 2024)
TRASTUZUMAB PLUS GEMCITABINE-CISPLATIN FOR TREATMENT-NAIVE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE BILIARY TRACT ADENOCARCINOMA: A MULTICENTER, OPEN-LABEL, PHASE II STUDY (TAB). (11 Giugno 2024)
FRUQUINTINIB VERSUS PLACEBO IN PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER (FRESCO-2): AN INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY. (26 Marzo 2024)
NANOLIPOSOMAIL IRINOTECAN WITH FLUOROURACIL AND FOLINIC ACID IN METASTATIC PANCREATIC CANCER AFTER PREVIOUS GEMCITABINE-BASED THERAPY (NAPOLI-1): A GLOBAL, RANDOMISED, OPEN-LABEL, PHASE 3 TRIAL. (26 Marzo 2024)
EFFECT OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY ON CYTOREDUCTIVE SURGERY IN GASTRIC CANCER WITH SYNCHRONOUS PERITONEAL METASTASES: THE PHASE III GASTRIPEC-I TRIAL. (12 Marzo 2024)
